Comparison 18. Oral propranolol versus oral prednisolone.
Outcome or subgroup title | No. of studies | No. of participants | Statistical method | Effect size |
---|---|---|---|---|
1 Severe adverse events | 1 | 19 | Risk Ratio (M‐H, Random, 95% CI) | 0.15 [0.02, 1.02] |
2 Adverse events: complications in general | 1 | 20 | Risk Ratio (M‐H, Random, 95% CI) | 0.22 [0.06, 0.78] |
3 Other measures of resolution: colour fading | 1 | 20 | Mean Difference (IV, Random, 95% CI) | ‐1.0 [‐3.08, 1.08] |
4 Other measures of resolution: mean size reduction | 1 | 20 | Mean Difference (IV, Random, 95% CI) | 23.20 [‐3.36, 49.76] |
5 Other measures of resolution: proportional change in the total surface area | 1 | 19 | Mean Difference (IV, Random, 95% CI) | 0.23 [‐0.08, 0.54] |